US Stock MarketDetailed Quotes

OGN Organon & Co

Watchlist

14.890
+0.160+1.09%

Close Nov 21 16:00 ET

14.890
0.0000.00%

Post 16:43 ET

3.83BMarket Cap2.95P/E (TTM)

Organon & Co Stock Forum

Jaguar8

Oct 28 08:26

NEWS

$Organon & Co (OGN.US)$
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%
The acquisition expands Organon's dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S.
BASEL, Switzerland and LONDON and NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Organon (NYSE: OGN), a global health...

Meltyy

Oct 11 01:22

🚨 M&A Update! 🚨

Keep an eye on these recently announced & closed M&As: 👀
🟢 Recently Announced:
⇒ $Organon & Co (OGN.US)$ to acquire Dermavant
⇒ $Rafael Holdings (RFL.US)$ to acquire Cyclo Tx
⇒Crown Lab to acquire $Revance Therapeutics (RVNC.US)$
⇒ $Recursion Pharmaceuticals (RXRX.US)$ merger with Exscientia
🔴 Recently Closed:
⇒ $Johnson & Johnson (JNJ.US)$ acquired V-Wave
⇒ Pharmacosmos acquired $GTHX
What companies will be next? 🤔

whqqq

Jul 29 21:17

Cramer’s Lightning Round: Do not sell Constellation Energy

$Bank of America (BAC.US)$ : ”...You buy some right here, you buy some maybe if it breaks 40. I think this company is selling very inexpensively, and it’s a good one.”
$Illumina (ILMN.US)$ : “No. No Illumina. I like Danaher.”
$Constellation Energy (CEG.US)$ : “This is a solar play that is a very good company. It’s up a huge amount versus a lot of other stocks...I think you buy some, please hold on to it, do not sell it.”
$Meta Platforms (META.US)$ : “I thin...

https://www.youtube.com/watch?v=X4PV1Nqu1QU

From YouTube

Moomoo AI

Apr 6 07:51

Organon's low P/E ratio is due to its predicted growth being less than the broader market. Shareholders accept this as they anticipate future earnings won't bring any pleasant surprises. The share price is unlikely to rise significantly soon under these conditions.

Organon & Co.'s (NYSE:OGN) Earnings Are Not Doing Enough For Some Investors

Moomoo AI

Feb 18 17:32

Analysts show increased negativity towards the business following recent results, reflected in a minor decrease in next year's EPS estimates. Despite predicted earnings decline, Organon's valuation is not expected to be significantly affected, but growth is anticipated to lag behind the industry.

Organon & Co. Just Beat EPS By 70%: Here's What Analysts Think Will Happen Next

Moomoo AI

Feb 14 11:44

Seeking Alpha analysts are growing more bullish on the Merck spinoff, despite Wall Street's neutral stance. Analysts Leo Nelissen and Gen Alpha highlight OGN's attractive yield as a reason for their Buy ratings.

Organon Gaining Momentum Ahead of Q4 Earnings

Bigmoney Dreamer

Nov 17, 2023 11:57

$Organon & Co (OGN.US)$ 📈

Moomoo AI

Nov 7, 2023 13:32

Despite the company's payout ratio not posing an immediate concern, the significant decline in earnings per share raises concerns about Organon from a dividend perspective. Therefore, caution is advised for potential investors considering Organon for its upcoming dividend.

Is It Worth Considering Organon & Co. (NYSE:OGN) For Its Upcoming Dividend?

moom lives

Aug 9, 2023 02:01

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.45%

U.S. stocks were lower after the close on Tuesday, as losses in the Basic Materials, Financials and Technology sectors led shares lower.
At the close in NYSE, the Dow Jones Industrial Average fell 0.45%, while the S&P 500 index lost 0.42%, and the NASDAQ Composite index lost 0.79%.
The best performers of the session on the Dow Jones Industrial Average were Amgen Inc ( $Amgen (AMGN.US)$ ), which rose 3.11% or 7.86 points t...